This article was originally published in The Tan Sheet
Amerifit Brands, a portfolio company of Charterhouse Group, announces Nov. 29 Bear Growth Capital Partners, a subsidiary of Bear Stearns made a $15 mil. growth equity investment in the company. "This investment also increases our equity base, which will allow us to continue to be aggressive acquirers of brands that fit our strategy," Amerifit CEO Cyrill Siewert says. On Nov. 1 Amerifit Nutrition announced its acquisition of CULTURELLE, a probiotic dietary supplement. "CULTURELLE is the top-selling brand in the chain drug category and one of the fastest growing in the natural food channel, according to IRI and SPINS data, respectively," Amerifit said...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.